Healthcare - Sector
SNDX is currently covered by 11 analysts with an average price target of $40. This is a potential upside of $30.87 (338.12%) from yesterday's end of day stock price of $9.13.
Our record on SNDX covers 27 analysts since 2008; 10 cover it today. Of the 183 price targets those analysts set on SNDX, 47 were reached (26%). The highest performance score on SNDX belongs to Edward White of H.C. Wainwright: 5.05, with 7 of 30 targets met in 495 days on average. The latest calls: David Dai of UBS cut the target to $33 from $37 with a Buy rating on 21 Aug 2026; Anupam Rama of JPMorgan cut the target to $40 from $45 with a Buy rating on 11 Aug 2026; Andres Maldonado of H.C. Wainwright cut the target to $38 from $40 with a Buy rating on 5 Aug 2026. Figures as of 18 Nov 2026.
Syndax Pharmaceuticals's activity chart (see below) currently has 240 price targets and 185 ratings on display. The stock rating distribution of SNDX is 100% BUY.
Analysts' price targets on this stock were met 22.54% of the time, taking 179 days on average.
Highest price target for SNDX is $57, Lowest price target is $29, average price target is $40.
Most recent stock forecast was given by DAVID DAI from UBS. First documented stock forecast 27-Mar-2016.
Currently out of the existing stock ratings of SNDX, 24 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Oct-2024
$31
$21.87 (239.54%)
$33
1 days ago
(19-Nov-2026)
Buy Since 15-Oct-2025
$36
$26.87 (294.30%)
$38
18 days ago
(02-Nov-2026)
0/8 (0%)
$21.71 (151.92%)
Buy Since 02-Jan-2023
$40
$30.87 (338.12%)
$45
3 months 10 days ago
(10-Aug-2026)
0/16 (0%)
$19.71 (97.14%)
Buy Since 26-Feb-2026
$46
$36.87 (403.83%)
$46
5 months 6 days ago
(14-Jun-2026)
0/4 (0%)
$27.52 (148.92%)
Buy Since 29-Jan-2023
$31
$21.87 (239.54%)
$34
5 months 9 days ago
(11-Jun-2026)
0/9 (0%)
$12.75 (69.86%)
What is SNDX (Syndax Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on SNDX (Syndax Pharmaceuticals)?
Which analyst has the most public recommendations on SNDX (Syndax Pharmaceuticals)?
Which analyst is the currently most bullish on SNDX (Syndax Pharmaceuticals)?
Which analyst is the currently most reserved on SNDX (Syndax Pharmaceuticals)?